4.8 (239) In stock
PDF) The RNU2 macrosatellite : characterization, evolution and link with breast cancer genetic predisposition
The potential of epigenetic therapy to target the 3D epigenome in endocrine- resistant breast cancer
Résistance hormonale, méthylation et cancer du sein - CRCL
A Gender-Dependent Molecular Switch of Inflammation via MyD88/Estrogen Receptor-Alpha Interaction - CRCL-Résistance hormonale, méthylation et cancer du sein
Résistance hormonale, méthylation et cancer du sein - CRCL
An epigenetic signature of advanced colorectal cancer metastasis - ScienceDirect
Free Radicals–Mediated Epigenetic Changes and Breast Cancer Progression
Nuclear PRMT5 is a biomarker of sensitivity to tamoxifen in ERα+ breast cancer
Long-term airborne dioxin exposure and breast cancer risk in a case-control study nested within the French E3N prospective cohort - CRCL-Résistance hormonale, méthylation et cancer du sein
